Beeline Medicines
Last verified 2026-05-17. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $300.0Mattributed |
|---|---|
| Latest round | series-a, $300.0M, 2026-04-01attributed |
| Founded | 2025 |
| Headquarters | Stamford, USA |
| Industry | bio |
| Stage | series-a |
| Website | beelinemedicines.com |
Clinical-stage precision-immunology biotech with a five-program autoimmune pipeline in-licensed from Bristol Myers Squibb. Builds therapies for patients with lupus, atopic dermatitis, psoriasis and other autoimmune conditions. Launched with $300M from Bain Capital and led by Saqib Islam, who took SpringWorks through two FDA approvals.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2026-04-01 | series-a | $300.0M | undisclosed |
Detected tech stack
Cloudflare, WordPress, Modernizr, Yoast SEO 27.6, reCAPTCHA, Genesis theme, Google Tag Manager, Font Awesome, jQuery Migrate 3.4.1, Elementor 4.0.9, Cloudflare Bot Management, WP Engine
Provenance
| Fact | Status | Basis |
|---|---|---|
| Series A, $300.0M | attributed | crunchbase named as publisher. No document URL on file. |
| Total raised $300.0M | attributed | crunchbase named as publisher. No document URL on file. |
| Company existence | self-reported | beelinemedicines.com, read 2026-05-17 |
| Description | self-reported | beelinemedicines.com, read 2026-05-17 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
No change recorded since records began on 2026-09-24.